Chronic Obstructive Pulmonary Disease and Uncomplicated Bronchitis
If patients with chronic obstructive pulmonary disease and acute uncomplicated bronchitis show signs of bacterial infection, such as increased purulence of sputum, along with increased dyspnea and/or volume of sputum, antibiotic treatment should be limited to 5 days' duration.
Antibiotic choice is based on the most common bacterial etiologies, which include Haemophilus influenzae, Streptococcus pneumoniae, and Moraxella catarrhalis.
Recommended therapeutic agents include aminopenicillin with clavulanic acid, macrolides, and tetracyclines.
The minimum duration of antibiotic therapy for community-acquired pneumonia is 5 days. Any extension of antibiotic therapy beyond 5 days should be based on validated measures of clinical stability; these measures include (1) resolution of vital sign abnormalities, (2) ability to eat, and (3) normal mentation.
Antibiotic choice is based on the most common bacterial etiologies, which include S pneumoniae, H influenzae, Mycoplasma pneumoniae, and Staphylococcus aureus, along with atypical pathogens (eg, Legionella species).
Recommended therapeutic agents include amoxicillin, doxycycline, or a macrolide in healthy adults or, in patients with comorbidities, a beta-lactam with a macrolide or a respiratory fluoroquinolone.
Urinary Tract Infections
In men or women who have uncomplicated pyelonephritis, the recommendation is for a short course of antibiotic therapy with either fluoroquinolones (5-7 days) or trimethoprim-sulfamethoxazole (14 days), based on antibiotic susceptibility.
In women with uncomplicated bacterial cystitis, the recommendation is for a short course of antibiotics with nitrofurantoin (5 days), trimethoprim-sulfamethoxazole (3 days), or fosfomycin (single dose).
For nonpurulent cellulitis, a 5- to 6-day course of antibiotic therapy active against streptococcal species is recommended (eg, cephalosporin, penicillin, clindamycin); this is particularly appropriate for patients who are able to self-monitor and for those who have close follow-up primary care.
These recommendations do not apply to patients with purulent cellulitis (eg, abscesses, furuncles, carbuncles) or suspected infection with methicillin-resistant S aureus (MRSA).
For more information, please go to Chronic Obstructive Pulmonary Disease (COPD), Bronchitis, Community-Acquired Pneumonia (CAP), Urinary Tract Infection (UTI) and Cystitis (Bladder Infection) in Females, Urinary Tract Infection (UTI) in Males, and Cellulitis.
Medscape © 2021 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Short-Course Antibiotic Prescribing Clinical Practice Guidelines (ACP, 2021) - Medscape - Apr 29, 2021.